Loading...
01/11 10:50
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights strong financial performance, with a 37% YoY EBITDA growth and robust revenue increases in both Concorde and UTI divisions. The Q&A section indicates potential for future growth through accelerated campus expansions and program launches. While EBITDA margin expansion may be muted due to investments, the optimistic guidance for Q4 and beyond, along with strategic capital deployment, suggests a positive outlook. The lack of detailed guidance on buybacks and M&A is a minor concern but does not overshadow the overall positive sentiment.
Revenue Revenue for the third quarter increased 15% year-over-year to $204.3 million. This growth was driven by continued demand for skilled collar jobs and strategic investments to grow reach.
Net Income Net income increased roughly 114% year-over-year to $10.7 million. This was attributed to strong operational execution and demand for skilled trades education.
Adjusted EBITDA Adjusted EBITDA grew over 37% year-over-year to $25.3 million. This reflects strong top-line performance and operational execution.
Average Full-Time Active Students Average full-time active students grew nearly 13% year-over-year to 23,757 students. This growth was driven by program expansions and robust market demand.
New Student Starts Total new student starts increased approximately 3% year-over-year in the quarter. This was supported by sustained investments in marketing and admissions.
Concorde Division Revenue Concorde division revenue increased 20.7% year-over-year to $72.8 million. This growth was driven by sustained demand for careers in allied health and nursing, as well as operational excellence in marketing investments.
UTI Division Revenue UTI division revenue increased 12.2% year-over-year to $131.5 million. This was due to strong demand for skilled collar graduates and program expansions.
Operating Cash Flow Year-to-date operating cash flow was $40.2 million. This reflects strong financial performance and operational execution.
Adjusted Free Cash Flow Year-to-date adjusted free cash flow was $15 million. This was driven by strong top-line performance and disciplined capital expenditure management.
Short-term credential programs: The company is moving aggressively into the short-term credential space, with new opportunities created by recent legislation making some short courses Pell-eligible.
HVACR program expansion: Added HVACR programs to Rancho Cucamonga and Miramar campuses, expanding the program's footprint to 11 campuses across 7 states.
Aviation program milestone: Graduated the first class from aviation maintenance programs at Avondale and Long Beach campuses. Houston-based aviation students won first place at the 2025 Aerospace Maintenance Competition.
New campus launches: Two new UTI campuses set to open in 2026 in Atlanta and San Antonio, projected to generate $45 million and $23 million in revenue, respectively.
Concorde Career Colleges expansion: Plans to increase Dallas nursing program capacity, launch a new nursing program in Jacksonville, Florida, and roll out 10 non-Title IV short course programs across Concorde campuses.
Revenue growth: Revenue for Q3 2025 increased 15% year-over-year to $204.3 million.
Student growth: Average full-time active students grew nearly 13% year-over-year to 23,757 students.
Adjusted EBITDA: Grew over 37% year-over-year to $25.3 million.
North Star Strategy Phase II: Outlines achieving over $1 billion in yearly revenue and approaching $200 million in adjusted EBITDA by fiscal 2029.
Concorde Career Colleges growth unlocked: Restrictions lifted, enabling accelerated program and campus growth starting next fiscal year, one year ahead of plan.
Regulatory and Legislative Risks: While the current regulatory environment is supportive, there is a dependency on continued favorable policies. Any changes in legislation or regulatory priorities could adversely impact the company's operations, particularly in areas like Pell-eligibility for short-term programs.
New Student Enrollment Challenges: The UTI division experienced a slight decline in new student starts in Q3, reflecting a 3% year-over-year decrease. This could indicate potential challenges in maintaining enrollment growth, which is critical for revenue and long-term sustainability.
Growth Investment Costs: The company is incurring significant growth investment expenses related to new program launches and campus build-outs. These investments, while necessary for long-term growth, are expected to temporarily moderate margin growth over the next two years.
Dependence on Economic Conditions: The company's performance is closely tied to demand for skilled trades and allied health sectors. Any economic downturn or reduced demand in these sectors could negatively impact enrollment and revenue.
Execution Risks in Expansion: The company has ambitious plans for campus and program expansions, including new locations and program types. Delays or issues in execution could lead to cost overruns or failure to meet revenue targets.
Competitive Pressures: The company operates in a competitive education market. Failure to differentiate its offerings or respond to competitive pressures could impact its market share and financial performance.
Revenue Guidance for Fiscal 2025: The company has raised its fiscal 2025 revenue guidance to a range of $830 million to $835 million, reflecting approximately 14% year-over-year growth at the midpoint.
New Student Starts Guidance for Fiscal 2025: Total new student starts are now anticipated to range between 29,500 and 30,000 for fiscal 2025.
Adjusted EBITDA Guidance for Fiscal 2025: Full year adjusted EBITDA is expected to be between $124 million and $128 million, representing around a 23% year-over-year increase at the midpoint.
Net Income and EPS Guidance for Fiscal 2025: Net income is anticipated to be between $56 million and $60 million, with diluted earnings per share of $1 to $1.08 for the year.
Adjusted Free Cash Flow Guidance for Fiscal 2025: Full year adjusted free cash flow is anticipated to range between $62 million and $68 million.
Concorde Career Colleges Expansion: The company plans to accelerate Concorde's program and campus growth starting in fiscal 2026, one year ahead of plan, following the lifting of core growth restrictions by the Department of Education.
Campus Expansion Plans: Two new UTI campuses are set to open in 2026, pending regulatory approvals. The Atlanta campus will offer a comprehensive set of programs, and the San Antonio campus will focus on skilled trades. These campuses are expected to generate $45 million and $23 million in revenue, respectively, once fully ramped.
Long-Term Revenue and EBITDA Targets: The company aims to achieve over $1 billion in yearly revenue and approach $200 million in adjusted EBITDA by fiscal 2029 as part of its North Star Strategy Phase II.
The selected topic was not discussed during the call.
The earnings call indicates strong financial performance with revenue and net income exceeding guidance, and positive growth in student starts. The Q&A section provided clarifications without raising major concerns, and guidance was raised. Despite a slight miss in free cash flow, the overall sentiment is positive due to robust demand and strategic expansion plans. The market is likely to react positively over the next two weeks, especially with optimistic guidance and expansion plans.
The earnings call highlights strong financial performance, with a 37% YoY EBITDA growth and robust revenue increases in both Concorde and UTI divisions. The Q&A section indicates potential for future growth through accelerated campus expansions and program launches. While EBITDA margin expansion may be muted due to investments, the optimistic guidance for Q4 and beyond, along with strategic capital deployment, suggests a positive outlook. The lack of detailed guidance on buybacks and M&A is a minor concern but does not overshadow the overall positive sentiment.
The earnings call revealed strong financial performance with revenue and net income growth, optimistic guidance, and strategic investments in marketing and program expansion. The addition of Tesla as a partner is a positive catalyst. Despite some vagueness in management's responses during the Q&A, the overall sentiment remains positive due to the company's strong market positioning and demand for skilled labor. The stock is likely to react positively, especially if it's a small-cap stock, due to the strong financial results and optimistic outlook.
The earnings call presents a positive outlook with strong financial performance, including a 13% revenue increase and 47% net income growth. The company announced a partnership with Tesla, which boosts sentiment. Despite challenges like regulatory risks and competitive pressures, the optimistic guidance and strategic investments in new campuses and programs indicate future growth. The Q&A session highlighted strong demand in skilled trades and healthcare, further supporting a positive sentiment. However, the lack of a share repurchase program and unclear future EBITDA growth slightly temper the outlook, resulting in a 'Positive' rating.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
